Session » Epidemiology and Public Health Poster III: Rheumatic Disease Risk and Outcomes

Date: Tuesday, November 7, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1956

An Approach to Linkage of Registry Data to Medicare Claims Using Multiple Non-Unique Identifiers

9:00AM-11:00AM: Abstract Number: 1971

Association between Genetic Variants and the Presence of Rheumatoid Arthritis-Related Autoimmunity and Progression to Classified Rheumatoid Arthritis in an at-Risk Population

9:00AM-11:00AM: Abstract Number: 1963

Association of Corticosteroid Exposure with Ophthalmologic Complications and Systemic Adverse Events in Non-Infectious Uveitis Patients Using Administrative Claims in the United States

9:00AM-11:00AM: Abstract Number: 1954

Association of CRP with BMI in Males and Females

9:00AM-11:00AM: Abstract Number: 1958

Burden of Rheumatic Disease Among Korean Women in Childbearing Years Based on the National Health Insurance Service-National Sample Cohort

9:00AM-11:00AM: Abstract Number: 1972

Causes of Death in 350 Patients with Systemic Autoimmune Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1950

Cross-Sectional Analysis of Foot Osteoarthritis Frequency and Associated Factors: The Johnston County Osteoarthritis Project

9:00AM-11:00AM: Abstract Number: 1953

Dietary Quality and Risk of SLE in the Nurses’ Health Studies

9:00AM-11:00AM: Abstract Number: 1951

Effect of Initiating Metformin Vs. Sulfonylureas on the Risk of Total Knee Arthroplasty

9:00AM-11:00AM: Abstract Number: 1965

Evolution of Anti-Citrullinated Protein Antibodies in Post-Chikungunya Arthritis Patient in Dominican Republic

9:00AM-11:00AM: Abstract Number: 1955

Health Care Provider Advice for Weight Loss Among US Adults with Arthritis, National Health Interview Survey, 2014

9:00AM-11:00AM: Abstract Number: 1957

Impact of Maternal Systemic Autoimmune Rheumatic Diseases on Neonatal Outcomes: A Population-Level Analysis

9:00AM-11:00AM: Abstract Number: 1959

Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1960

National Survey of Childhood-Onset Rheumatic Diseases Followed up in the Clinical Pediatric Facilities in Japan

9:00AM-11:00AM: Abstract Number: 1968

Occurrence of Rheumatic Diseases in a National Cohort of Hospitalizations for Progressive Multifocal Leukoencephalopathy

9:00AM-11:00AM: Abstract Number: 1969

Prevalence and Predictive Value over 16 Years of Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies in the General Population

9:00AM-11:00AM: Abstract Number: 1962

Rates of Malignancy Associated with Anti-TNF Agents and Subsequent Biologic Use after Malignancy Using U.S. SEER Registry Data

9:00AM-11:00AM: Abstract Number: 1961

Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study

9:00AM-11:00AM: Abstract Number: 1966

Risk of Tuberculosis in Biologic Users for Rheumatic Diseases: Results from the South African Biologics Registry

9:00AM-11:00AM: Abstract Number: 1967

Strongyloides Screening in Immunocompromised Immigrant Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 1970

The Prevalence of Rheumatoid Arthritis and Allergic Diseases and Their Association : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)

9:00AM-11:00AM: Abstract Number: 1964

The Risk of Hydroxychloroquine Toxic Retinopathy and Its Risk Factors in the Treatment of Rheumatic Diseases: A Systematic Review

9:00AM-11:00AM: Abstract Number: 1952

Trend of Arthrocentesis Utilization Among Inpatients over 10 Years – Data from National Inpatient Sample

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].